Dysbiosis in phylogenetically diverse species associated with type 2 diabetes
Jun 26, 2024
Within-species phylogenetic diversity was identified for strains of 27 species that explain inter-individual differences in type 2 diabetes risk.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
Major drug companies agree to price negotiations with US government
Oct 03, 2023
Ten drugs have been chosen for price negotiations by the Centers for Medicare & Medicaid Services.
Sanofi follows Lilly, Novo Nordisk in cutting insulin prices
Mar 17, 2023
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Diabetes increases risk for functional limitations in older adults
May 03, 2024
The findings were seen even after controlling for sociodemographic and other health factors.
2012 to 2015 saw rise in US insulin prices
Jun 16, 2023
However, the introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices.